Scientific Library of Tomsk State University

   E-catalog        

Image from Google Jackets
Normal view MARC view

Essentials of Atrial Fibrillation electronic resource by Yee Guan Yap, A John Camm.

By: Yap, Yee Guan [author.]Contributor(s): Camm, A John [author.] | SpringerLink (Online service)Material type: TextTextPublication details: Tarporley : Springer Healthcare Ltd. : Imprint: Springer Healthcare, 2014Description: VIII, 47 p. 11 illus., 4 illus. in color. online resourceContent type: text Media type: computer Carrier type: online resourceISBN: 9781907673986Subject(s): medicine | Public health | Internal medicine | Cardiology | Hematology | Emergency medicine | Medicine & Public Health | Internal Medicine | Public Health | Cardiology | Hematology | Primary Care Medicine | PharmacotherapyDDC classification: 616 LOC classification: RC1-1245Online resources: Click here to access online
Contents:
Epidemiology of atrial fibrillation -- Pathogenesis of atrial fibrillation -- Classification, diagnosis, and assessment of atrial fibrillation -- Rate and rhythm control strategies for atrial fibrillation -- Anticoagulant treatment strategies for atrial fibrillation.
In: Springer eBooksSummary: This handbook offers timely investigation of current pharmaceutical trends, clinical guidelines, novel treatments, and ongoing pipeline developments, including ground-breaking advances in the use of novel oral anticoagulants. Atrial fibrillation (AF) affects an estimated 1–2% of the population and is the most common cause of sustained cardiac arrhythmia. Critically, the number of patients developing AF is expected to double in the next five decades, leading to increased incidence of stroke, heart failure and other serious thromboembolic events.
Tags from this library: No tags from this library for this title. Log in to add tags.
No physical items for this record

Epidemiology of atrial fibrillation -- Pathogenesis of atrial fibrillation -- Classification, diagnosis, and assessment of atrial fibrillation -- Rate and rhythm control strategies for atrial fibrillation -- Anticoagulant treatment strategies for atrial fibrillation.

This handbook offers timely investigation of current pharmaceutical trends, clinical guidelines, novel treatments, and ongoing pipeline developments, including ground-breaking advances in the use of novel oral anticoagulants. Atrial fibrillation (AF) affects an estimated 1–2% of the population and is the most common cause of sustained cardiac arrhythmia. Critically, the number of patients developing AF is expected to double in the next five decades, leading to increased incidence of stroke, heart failure and other serious thromboembolic events.

There are no comments on this title.

to post a comment.